Abstract
Abstract Introduction The COVID-19 pandemic prompted widespread implementation of non-pharmaceutical interventions (NPIs) to limit SARS-CoV-2 transmission. These interventions, including lockdowns, face covering, movement restrictions, and school closures, also altered circulation patterns of other pathogens. These measures were enforced on a large scale in Poland beginning in 2020 and persisted through 2022, introducing a rare opportunity to assess broader impacts on other communicable diseases. Previous research frequently addressed short-term alterations in disease incidence, yet knowledge of extended effects remains limited. Aim The study aimed to assess how the pandemic and associated measures changed the incidence of 17 notifiable infectious diseases in Poland from January 2014 to December 2022. The analysis investigated whether NPIs were correlated with immediate declines, sustained decreases, or rebounds in disease activity, with particular attention to changes in disease dynamics across pre-pandemic and pandemic phases, identifying severity of resurgent trends once restrictions were lifted. Materials and Methods Biweekly case counts for 17 notifiable diseases were collected from the National Institute of Public Health-National Institute of Hygiene, then aggregated into monthly intervals. The study period encompassed five phases: 2014-2018, 2019 (baseline), and each pandemic year (2020, 2021, 2022). Crude annual incidences were calculated and converted to percentage changes, with comparisons between baseline and pandemic periods as well as among individual pandemic years. Seasonality was removed with X13-ARIMA-SEATS, enabling clearer detection of incidence fluctuations. A two-stage negative binomial generalized linear model (GLM) controlled for autocorrelation and potential confounders, producing incidence rate ratios (IRRs) relative to the 2019 reference phase. The analysis evaluated nine NPIs, including school closure, stay-at-home orders, public gathering bans, and an overall stringency index. Spearman correlation coefficients measured associations between the deseasonalized disease time series, COVID-19 case counts, and each of the nine NPIs. Results Thirteen of the 17 diseases exhibited cumulative declines from 2020 to 2022 when compared to 2014-2019, ranging from 10.48% (syphilis) to 87.63% (whooping cough). The largest single-year drop appeared in 2021 for whooping cough, which showed a 94.56% decrease from 2019. Statistical modeling revealed an IRR of 0.32 (95%CI 0.24-0.42, p<0.001) in 2020 and 0.11 (95%CI 0.08-0.15, p<0.001) in 2021, exhibiting a significant, sustained reduction in incidence. Scarlet fever, chickenpox, and mumps followed a similar pattern, with IRRs persistently below 0.5 throughout at least one pandemic phase. Invasive Streptococcus pneumoniae remained reduced in 2020 (IRR 0.33 [0.24-0.46], p<0.001), yet rebounded in 2022 with an 88.94% rise over 2019. Clostridium difficile diverged from most other diseases, showing a 2.88% increase in 2020 and a jump of over 117% in 2021 compared to 2019, alongside an IRR of 1.84 (1.64-2.07, p<0.001). Noteworthy surges in norovirus (84.5% in 2021 vs. 2019), HIV (63.5% in 2022 vs. 2019), and syphilis (34.92% in 2022 vs. 2019) aligned with relaxation of NPIs. Correlations generally showed strong negative associations between respiratory pathogens and higher NPI stringency, while C. difficile displayed a positive relationship with COVID-19 case counts and several NPIs. These contrasting trends reflected the multifaceted ways that reduced mobility, physical distancing, and masking influenced various modes of disease transmission. Conclusion Long-term observation confirmed that widespread NPIs had a strong suppressive effect on many communicable diseases beyond SARS-CoV-2, particularly those transmitted via respiratory droplets. Several infections rebounded when NPIs were relaxed, indicating potential shifts in susceptibility within the population. Future strategies aiming to balance public health protection with social and economic priorities may benefit from these findings, although additional research is needed to clarify how evolving interventions and changing pathogen transmission patterns influence disease resurgence over extended timeframes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data was sourced from publically available reports published by the National Institute of Public Health, National Institute of Hygiene - National Research Institute (NIPH NIH-NRI) of Poland. https://www.pzh.gov.pl/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
